Dragon’s Blood—an umbrella term for the red resin derived from several plant species such as Croton lechleri, Daemonorops draco, and Dracaena cinnabari—has a long history of use in traditional medicine for wound healing and skin regeneration. In recent years, there has been emerging scientific interest in its potential to support wound healing and reduce scar formation. Several studies, primarily in vitro and animal models, have demonstrated that Dragon’s Blood exhibits anti-inflammatory, antioxidant, and antimicrobial effects, which are beneficial for tissue repair. For example, research on Croton lechleri extracts has shown promotion of fibroblast proliferation and enhancement of collagen deposition—both key factors in wound healing and scar modulation (Menezes et al., 2014). A few small clinical studies and case reports suggest that topical formulations containing Dragon's Blood may improve wound closure rates and aesthetic outcomes of scars, but high-quality randomized controlled trials are limited.

Overall, while traditional use for scars and wound healing is strong, scientific validation is moderate, with biological plausibility supported by preclinical data. More rigorous human studies are needed to firmly establish efficacy for scar treatment. The current evidence supports a rating of 3 out of 5.